Comparative Efficacy and Safety of Deferoxamine, Deferiprone and Deferasirox on Severe Thalassemia: A Meta-Analysis of 16 Randomized Controlled Trials-Reference-Cited by-同舟云学术

Comparative Efficacy and Safety of Deferoxamine, Deferiprone and Deferasirox on Severe Thalassemia: A Meta-Analysis of 16 Randomized Controlled Trials

Published:2013-12-23 Issue:12 Volume:8 Page:e82662
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Xia Sujian,Zhang Weidong,Huang Liting,Jiang Hong

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. Changing patterns of thalassemia worldwide;EP Vichinsky;Ann N Y Acad Sci,2005

2. Global epidemiology of haemoglobin disorders and derived service indicators;B Modell;Bull World Health Organ,2008

3. Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major;NF Olivieri;N Engl J Med,1998

4. Meta-analytic review of the clinical effectiveness of oral deferiprone (L1);A Addis;Eur J Clin Pharmacol,1999

5. Effects of combined deferiprone with deferoxamine on right ventricular function in thalassaemia major;F Alpendurada;J Cardiovasc Magn Reson,2012

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Deferasirox and Desferrioxamine in Term of Mean Serum Ferritin Levels in Patients of β-Thalassemia Major with Iron Overload;Pakistan Journal of Health Sciences;2024-08-31

2. Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemia;Cochrane Database of Systematic Reviews;2023-11-17

3. Grape seed extract in combination with deferasirox ameliorates iron overload, oxidative stress, inflammation, and liver dysfunction in beta thalassemia children;Complementary Therapies in Clinical Practice;2023-11

4. Prevalence and Management of Transfusional Iron Overload in Syrian Beta Thalassemia Major Patients Pre and during the Syrian Conflict;BioMed Research International;2023-09-14

5. The iron chelator deferriferrichrysin induces paraptosis via extracellular signal‐related kinase activation in cancer cells;Genes to Cells;2023-06